Vivax Elimination With Tafenoquine (VET) Study

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

February 19, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
MalariaMalaria, VivaxPlasmodium VivaxPlasmodium Vivax Malaria
Interventions
DRUG

Tafenoquine

"Tafenoquine KODATEF® 100 mg film-coated tablets will be purchased from Biocelect (Suite 5.02, Level 5, 139 Macquarie Street, Sydney NSW, 2000 Australia).~Tafenoquine will be given as follows,~\>10 kg to ≤ 20 kg - 150 mg (1 tab), \>20 kg to ≤ 35 kg - 300 mg (2 tabs), \> 35 kg - 450 mg (3 tabs)"

Trial Locations (1)

Unknown

Shoklo Malaria Research Unit (SMRU), Mae Sot

All Listed Sponsors
collaborator

Mahidol Oxford Tropical Medicine Research Unit

OTHER

lead

Shoklo Malaria Research Unit

OTHER

NCT06575647 - Vivax Elimination With Tafenoquine (VET) Study | Biotech Hunter | Biotech Hunter